3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
15
Breast Neoplasms
13
Leukemia, Myeloid, Acute
11
Carcinoma, Non-Small-Cell Lung
11
Glioblastoma
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
8
Brain Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Mantle-Cell
7
Leukemia
7
Multiple Myeloma
6
Hodgkin Disease
6
Neoplasms
5
Myelodysplastic Syndromes
5
Lymphoma, T-Cell, Cutaneous
5
Lung Neoplasms
5
Gliosarcoma
5
Congenital Abnormalities
5
Breast Neoplasms, Male
5
Recurrence
4
Lymphoma, Large-Cell, Anaplastic
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Immunoblastic Lymphadenopathy
4
Interventions
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
LY3023414
2
sonidegib
1
sodium thiosulfate
1
ensartinib
1
cixutumumab
1
cabozantinib
1
Restraint, Physical
1
Pharmacogenomic Variants
1
MLN 8237
1
Cyproheptadine
1
Arsenic Trioxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatoblastoma
×
Vorinostat
×
Clear all
No trials found.